INT334498

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.00
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.63
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

intracellular (KLF1) DNA binding (KLF1) cell-cell signaling (IL13)
cytoplasm (IL13) extracellular space (IL13) signal transduction (IL13)
IL13 (Homo sapiens)
KLF1 (Homo sapiens)
Pain Link Frequency Relevance Heat
cytokine 14 19.68 Low Low
Inflammation 15 10.88 Low Low
agonist 7 5.00 Very Low Very Low Very Low
corticosteroid 6 5.00 Very Low Very Low Very Low
antagonist 4 5.00 Very Low Very Low Very Low
adenocard 1 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
pruritus 1 5.00 Very Low Very Low Very Low
tolerance 1 5.00 Very Low Very Low Very Low
chemokine 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Asthma 50 98.52 Very High Very High Very High
Airway Remodeling 2 81.32 Quite High
Eczema 2 62.32 Quite High
Diabetes Mellitus 1 14.88 Low Low
INFLAMMATION 14 10.88 Low Low
Hypersensitivity 28 5.00 Very Low Very Low Very Low
Disease 11 5.00 Very Low Very Low Very Low
Rhinitis 9 5.00 Very Low Very Low Very Low
Respiratory Disease 3 5.00 Very Low Very Low Very Low
Anaphylaxis 3 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Lebrikizumab is a humanized monoclonal antibody that binds to IL-13 and is currently in development for asthma (ClinicalTrials.gov Identifier: NCT00930163).
IL-13 Binding (binds) of monoclonal associated with asthma
1) Confidence 0.00 Published 2010 Journal Allergy, Asthma & Immunology Research Section Body Doc Link PMC2946700 Disease Relevance 0.63 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox